Characterization of vascular endothelial cell growth factor interactions with the kinase insert domain-containing receptor tyrosine kinase - A real time kinetic study

被引:43
作者
Cunningham, SA
Tran, TM
Arrate, MP
Brock, TA
机构
[1] Texas Biotechnol Corp, Dept Pharmacol, Houston, TX 77030 USA
[2] Univ Texas, Hlth Sci Ctr, Dept Integrat Biol Physiol & Pharmacol, Houston, TX 77225 USA
关键词
D O I
10.1074/jbc.274.26.18421
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The kinase insert domain-containing receptor (KDR) tyrosine kinase mediates calcium mobilization in endothelial cells and plays a key role during physiological and pathological angiogenesis, To provide a detailed understanding of how KDR is activated, we analyzed the kinetics of ligand-receptor interaction using BIAcore. Both predimerized (KDR-Fc) and monomeric (KDR-cbu) receptors were examined with vascular endothelial cell growth factor (VEGF) homodimers and VEGF/placental growth factor (PIGF) heterodimers. VEGF binds to KDR-Fc with k(a) = 3.6 +/- 0.07e(6), k(d) = 1.54 +/- 0.19e(-4), and K-D = 37.1 +/- 4.9 pM. These values are similar to those displayed by monomeric KDR where k(a) = 5.23 +/- 1.4e(6), k(d) = 2.74 +/- 0.76e(-4), and KD = 51.7 +/- 5.8 pM were apparent. In contrast, VEGF/PIGF bound to KDR-Fc with k(a) = 7.3 +/- 1.6e(4), k(d) = 4.4 +/- 1.2e(-4), and K-D = 6 +/- 1.2 nM. Thus, the heterodimer displays a 160-fold reduced K-D for binding to predimerized KDR, which is mainly a consequence of a 50-fold reduction in k(a). We were unable to detect association between VEGF/PIGF and monomeric KDR. However, nanomolar concentrations of VEGF/ PIGF were able to elicit weak calcium mobilization in endothelial cells. This latter observation may indicate partial predimerization of KDR on the cell surface or facilitation of binding due to accessory receptors.
引用
收藏
页码:18421 / 18427
页数:7
相关论文
共 41 条
  • [1] Barleon B, 1997, J BIOL CHEM, V272, P10382
  • [2] BIACORE AB, 1997, BIAEVALUATION
  • [3] Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
    Carmeliet, P
    Ferreira, V
    Breier, G
    Pollefeyt, S
    Kieckens, L
    Gertsenstein, M
    Fahrig, M
    Vandenhoeck, A
    Harpal, K
    Eberhardt, C
    Declercq, C
    Pawling, J
    Moons, L
    Collen, D
    Risau, W
    Nagy, A
    [J]. NATURE, 1996, 380 (6573) : 435 - 439
  • [4] COA Y, 1996, J BIOL CHEM, V271, P3154
  • [5] Identification of the extracellular domains of Flt-1 that mediate ligand interactions
    Cunningham, SA
    Stephan, CC
    Arrate, MP
    Ayer, KG
    Brock, TA
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 231 (03) : 596 - 599
  • [6] KDR activation is crucial for VEGF165-mediated Ca2+ mobilization in human umbilical vein endothelial cells
    Cunningham, SA
    Tran, TM
    Arrate, MP
    Bjercke, R
    Brock, TA
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1999, 276 (01): : C176 - C181
  • [7] The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade
    DavisSmyth, T
    Chen, H
    Park, J
    Presta, LG
    Ferrara, N
    [J]. EMBO JOURNAL, 1996, 15 (18) : 4919 - 4927
  • [8] THE FMS-LIKE TYROSINE KINASE, A RECEPTOR FOR VASCULAR ENDOTHELIAL GROWTH-FACTOR
    DEVRIES, C
    ESCOBEDO, JA
    UENO, H
    HOUCK, K
    FERRARA, N
    WILLIAMS, LT
    [J]. SCIENCE, 1992, 255 (5047) : 989 - 991
  • [9] PURIFICATION AND CHARACTERIZATION OF A NATURALLY-OCCURRING VASCULAR ENDOTHELIAL GROWTH-FACTOR PLACENTA GROWTH-FACTOR HETERODIMER
    DISALVO, J
    BAYNE, ML
    CONN, G
    KWOK, PW
    TRIVEDI, PG
    SODERMAN, DD
    PALISI, TM
    SULLIVAN, KA
    THOMAS, KA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (13) : 7717 - 7723
  • [10] Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
    Ferrara, N
    CarverMoore, K
    Chen, H
    Dowd, M
    Lu, L
    OShea, KS
    PowellBraxton, L
    Hillan, KJ
    Moore, MW
    [J]. NATURE, 1996, 380 (6573) : 439 - 442